SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001640334-24-001338
Filing Date
2024-08-21
Accepted
2024-08-21 16:05:19
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 lxrp_424b5.htm 424B5 267987
2 lxrp_24b5img1.jpg GRAPHIC 5938
3 lxrp_24b5img2.jpg GRAPHIC 3551
4 lxrp_24b5img3.jpg GRAPHIC 5950
5 lxrp_24b5img4.jpg GRAPHIC 3546
6 lxrp_24b5img5.jpg GRAPHIC 3999
  Complete submission text file 0001640334-24-001338.txt   301448
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 424B5 | Act: 33 | File No.: 333-262402 | Film No.: 241228768
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)